Moisés Willian Aparecido Gonçalves

Moisés Willian Aparecido Gonçalves

Auto-generated profile, based on publicly available information

Moisés Willian Aparecido Gonçalves

Department of Pathology, School of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil; Department of Oral Diagnosis, Piracicaba Dental School, Universidade Estadual de Campinas (UNICAMP), Piracicaba, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2024 in Journal of Stomatology Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MGMoisés Willian Aparecido Gonçalves
Moisés Willian Aparecido Gonçalves
RLReydson Alcides de Lima-Souza
Reydson Alcides de Lima-Souza
MRMaria Clara Falcão Ribeiro-De-Assis
Maria Clara Falcão Ribeiro-De-Assis
MCMarcelo Elias Schempf Cattan
Marcelo Elias Schempf Cattan
EEErika Said Abu Egal
Erika Said Abu Egal
FMFernanda Mariano
Fernanda Mariano

5 November 2022 in Journal of Stomatology Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MSMarina Rocha Fonseca Souza
Marina Rocha Fonseca Souza
MGMoisés Willian Aparecido Gonçalves
Moisés Willian Aparecido Gonçalves
GSGlaciele Maria de Souza
Glaciele Maria de Souza
IFIghor Andrade Fernandes
Ighor Andrade Fernandes
SFSaulo Gabriel Moreira Falci
Saulo Gabriel Moreira Falci
EGEndi Lanza Galvão
Endi Lanza Galvão

13 August 2024 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
FRFernanda Cristina Poscai Ribeiro
Fernanda Cristina Poscai Ribeiro
NONadine Vieira de Oliveira
Nadine Vieira de Oliveira
GCGabriela Regonha Coral
Gabriela Regonha Coral
ACAlcântara Ramos de Assis César
Alcântara Ramos de Assis César
MGMoisés Willian Aparecido Gonçalves
Moisés Willian Aparecido Gonçalves
KPKleber Fernando Pereira
Kleber Fernando Pereira

16 December 2022 in Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
PDF file
MSMarina Rocha Fonseca Souza
Marina Rocha Fonseca Souza
MGMoisés Willian Aparecido Gonçalves
Moisés Willian Aparecido Gonçalves
GSGlaciele Maria de Souza
Glaciele Maria de Souza
IFIghor Andrade Fernandes
Ighor Andrade Fernandes
EGEndi Lanza Galvão
Endi Lanza Galvão
SFSaulo Gabriel Moreira Falci
Saulo Gabriel Moreira Falci

15 May 2024 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
EGEndi Lanza Galvão
Endi Lanza Galvão
KSKathiaja Miranda Souza
Kathiaja Miranda Souza
MFMarina Gonçalves de Freitas
Marina Gonçalves de Freitas
MSMarina Rocha Fonseca Souza
Marina Rocha Fonseca Souza
MGMoisés Willian Aparecido Gonçalves
Moisés Willian Aparecido Gonçalves
SSSarah Nascimento Silva
Sarah Nascimento Silva
Background: Proper treatment for brucellosis is crucial to eradicate the infection and prevent complications, but there is a notable gap in evidence for pediatric treatment. This study aims to address this gap by reviewing current literature, analyzing the efficacy and safety of brucellosis treatment in children, and identifying areas that require further investigation. Methods: A systematic review, following preferred reporting items for systematic reviews and meta-analyses and Cochrane Handbook guidelines, assessed antimicrobial regimens’ efficacy and safety for treating human brucellosis in children. Original human studies with clinical outcomes after drug therapy intervention for children up to 10 years were included. Searches were conducted in Medline, Embase, Cochrane Library and LILACS databases for studies indexed until March 6, 2023. Study selection, data extraction, and bias risk assessment were performed by pairs of reviewers. The quality assessment used Joanna Briggs Institute tools and grading of recommendations assessment, development and evaluation system. Data were analyzed using R software. Results: A total of 1773 records were reviewed, yielding 11 eligible studies encompassing 1156 children. All included studies presented an observational design. The most reported treatment approaches included sulfamethoxazole-trimethoprim with rifampicin or aminoglycosides, with summarized failure rates of 2% (95% confidence interval: 0.0–0.49) and 13% (95% confidence interval: 0.06–0.29), respectively (very low certainty of evidence). Adverse events and time to defervescence were not reported. Conclusions: Sulfamethoxazole-trimethoprim + rifampicin were the most prescribed antibiotics for brucellosis for pediatrics. The study highlights the need for more research with robust designs, and emphasizes uncertainty regarding the efficacy of antimicrobial regimens, emphasizing the importance of further investigations to guide specific treatment protocols for this population.

29 November 2023 in Heliyon
Verified
Journal Article
Open access
MGMoisés Willian Aparecido Gonçalves
Moisés Willian Aparecido Gonçalves
MSMarina Rocha Fonseca Souza
Marina Rocha Fonseca Souza
MBMarco Túllio Becheleni
Marco Túllio Becheleni
EGEndi Lanza Galvão
Endi Lanza Galvão
Essam Ahmed Al-MoraissiEssam Ahmed Al-Moraissi
Essam Ahmed Al-Moraissi
SFSaulo Gabriel Moreira Falci
Saulo Gabriel Moreira Falci
Tissue synthesis is extremely important for the attenuation of postoperative discomforts, as it keeps the tissues coapted, accelerates the healing process, and reduces the bleeding period of the surgical wound. Thus, this study aimed to systematically review the results of clinical trials that compared the use of cyanoacrylate with conventional sutures after third molars extraction. Searches were conducted on MEDLINE (via PubMed), Cochrane Central Registry of Controlled Trials (CENTRAL), Virtual Health Library (VHL), and Web of Science. Articles published up to February 20, 2022, were included. No restrictions were imposed on data or language of publication. A total of 8 studies (5 randomized controlled trials and 3 non-randomized comparative clinical studies) were included in this review and five studies were included in the meta-analysis, comprising 440 patients. The use of cyanoacrylate promoted better results in pain reduction in the first postoperative day when compared to the use of conventional suture (SMD: −1.01; 95%CI -1.90 to −0.12). Cyanoacrylate group promoted significant but borderline edema reduction compared to conventional sutures in the 7th postoperative day (SMD: −0.24, 95%CI -0.46 to −0.01, I2 = 0 %). For the trismus outcome, in all periods evaluated no differences were found between the groups. Although promising results, there is no high-quality evidence to suggest the use of cyanoacrylate was better than conventional sutures.